Skip to content
Peptide Oral Strips OEM & ODM  |  Private Label  |  Custom Peptide ODF Formulation  |  Fast Prototyping  |  Low-MOQ Project Review  |  Peptide Film R&D Service  |  One-Stop Manufacturing
Important: Some peptide formulation projects are for laboratory research only and are not for human or animal consumption. Every project must comply with applicable local regulations.
Get Quote
Peptide Oral Dissolving Film Solutions

Wellness & Vitality Peptide Oral Strips

Content updated · Evidence and updates

Wellness and vitality are product-positioning categories, not a specification or demonstrated outcome. Define the ingredient and serving before approving marketing copy.

How should a dietary peptide oral strip project be evaluated?

Begin a dietary oral strip project by identifying the ingredient source, intended use and destination market. The word peptide does not establish that a material is permitted in every supplement category, and a film format does not change the evidence needed for the ingredient or proposed claim. Separate technical development from the decision to place a finished product on a particular market. The formulation brief should state the target amount per strip and the planned number of strips per serving. Compare those figures with the ingredient information that supports the intended positioning. If the desired serving cannot be delivered in a practical film, revise the concept rather than assuming a smaller amount is equivalent. Agree the finished specification, labeling responsibilities and documentation requirements before artwork is finalized. Market review and analytical confirmation should remain linked to the exact commercial formulation.

  • Ingredient: identity, source, composition and permitted-use review.
  • Serving: mg per strip and strips per planned serving.
  • Evidence: relevance to the actual ingredient and finished amount.
  • Market: category, label, claims and importer responsibilities.

Can my peptide ingredient be made into an oral film?

Film feasibility depends on the complete ingredient specification and the required finished format, not the ingredient name alone. Start with identity, composition, source, target loading and any available analytical method. The development team then evaluates how the material behaves in a proposed polymer system during mixing, casting, drying and storage. A visually acceptable film is only one observation: the sample must also be assessed against agreed analytical and handling requirements. Separate the desired amount per strip from the amount demonstrated in a tested prototype. Film area, dry mass and composition should be reported together so the loading calculation can be checked. A formula change, including a new flavor or sweetener, may require another comparison round. The feasibility outcome should record the version tested, unresolved questions and conditions needed before a pilot decision.

  • Ingredient: identity, source, specification and test method.
  • Loading: target and measured mg per strip, clearly separated.
  • Film: length, width, thickness and dry mass with units.
  • Decision: accepted observations, failed criteria and next experiment.

Related 2026 ingredient concepts

Review the listed combinations and source codes alongside the existing project scope. A catalog reference does not change the ingredient specification, target population or claims permitted for a final product.

2026 Oral Film Portfolio

Essential Nutrition

Essential nutrition concepts cover vitamin C, vitamin C with zinc, vitamin D3 with calcium, vitamin D3 with vitamin K2, vitamin B12, a B vitamin combination, DHA, and biotin with zinc. The brochure supplies ingredient directions but does not provide a confirmed amount per strip. Each entry needs a separate assessment of ingredient identity, permitted use and the desired serving in the destination market. Confirm the proposed loading against film size and handling requirements, then evaluate a documented prototype. No finished-product dosage, shelf life, absorption result or commercial availability is established by this catalog. The listed combinations should not be used as consumer treatment advice. Agree labeling responsibilities and the evidence needed for any proposed statement before commercial artwork is approved. Refer to the original brochure codes when requesting a sample or discussing an alternative ingredient combination.

Brochure codeIngredient direction
B1Vitamin C
B2Vitamin C + Zinc
B3Vitamin D3 + Calcium
B4Vitamin D3 + Vitamin K2 (MK-7)
B5Vitamin B12
B6Vitamin B1 + Vitamin B2 + Vitamin B6
B7DHA
B8Biotin + Zinc
2026 Oral Film Portfolio

Brain Health & Sleep Concepts

This brochure category includes melatonin, melatonin with magnesium, L-theanine, L-theanine with caffeine, magnesium, DHA, a B vitamin combination and caffeine. The category name reflects the supplied presentation rather than a claim that every formulation improves sleep or cognitive performance. Each entry needs a separate assessment of ingredient identity, permitted use and the desired serving in the destination market. Confirm the proposed loading against film size and handling requirements, then evaluate a documented prototype. No finished-product dosage, shelf life, absorption result or commercial availability is established by this catalog. The listed combinations should not be used as consumer treatment advice. Agree labeling responsibilities and the evidence needed for any proposed statement before commercial artwork is approved. Refer to the original brochure codes when requesting a sample or discussing an alternative ingredient combination.

Brochure codeIngredient direction
C1Melatonin
C2Melatonin + Magnesium
C3L-theanine
C4L-theanine + Caffeine
C5Magnesium
C6DHA
C7Vitamin B complex
C8Caffeine
2026 Oral Film Portfolio

Children & Special-Population Concepts

The supplied portfolio lists children-oriented vitamin D3 with calcium, DHA, vitamin C, zinc and multivitamin directions, together with folic acid, iron with vitamin C, and a senior multivitamin concept. These entries identify intended formulation discussions, not evidence of suitability for every age or life stage. Each entry needs a separate assessment of ingredient identity, permitted use and the desired serving in the destination market. Confirm the proposed loading against film size and handling requirements, then evaluate a documented prototype. No finished-product dosage, shelf life, absorption result or commercial availability is established by this catalog. The listed combinations should not be used as consumer treatment advice. Agree labeling responsibilities and the evidence needed for any proposed statement before commercial artwork is approved. Refer to the original brochure codes when requesting a sample or discussing an alternative ingredient combination. Age limits and pregnancy-related positioning require an appropriate qualified review.

Brochure codeIngredient direction
E1Vitamin D3 + Calcium
E2DHA
E3Vitamin C
E4Zinc
E5Multivitamins
E6Folic acid
E7Iron + Vitamin C
E8Multivitamins
WhatsApp✆
Scroll to Top